Formulation and evaluation of ergotamine tartrate Lyophilized nasal insert
dc.Affiliation | October University for modern sciences and Arts (MSA) | |
dc.contributor.author | El-Telbany D.F. | |
dc.contributor.author | Tayel S.A. | |
dc.contributor.author | El-Nabarawi M.A. | |
dc.contributor.author | Tag R. | |
dc.contributor.author | Aboelwafa A.A. | |
dc.contributor.other | Pharmaceutics and Industrial Pharmacy | |
dc.contributor.other | MSA University | |
dc.contributor.other | Egypt; Pharmaceutics and Industrial Pharmacy | |
dc.contributor.other | Cairo University | |
dc.contributor.other | Egypt | |
dc.date.accessioned | 2020-01-09T20:42:09Z | |
dc.date.available | 2020-01-09T20:42:09Z | |
dc.date.issued | 2014 | |
dc.description | Scopus | |
dc.description.abstract | Lyophilized nasal inserts represent an alternative route for the administration of drugs. The aim of this study is to prepare a firm single dose unit of nasal insert containing ergotamine tartrate which allows easy administration in the nasal cavity and prevent first pass metabolism leading to increased bioavailability. The insert was prepared by applying freeze drying technique using 2% w/w of different polymers.The prepared inserts were evaluated for appearance, bioadhesion potential, water uptake, in vitro drug release and imaged by scanning electron microscopy.The results showed that the prepared nasal inserts have a smooth surface and a spongy-like appearance. No interaction occurred between the drug and different polymers as revealed in DSC and FT-IR. Higher viscosity of the polymer causes a greater degree of water uptake and high bioadhesion potential; this in turn reduces the drug release, as the diffusional path length of drug becomes longer. The study revealed an inverse relationship between water uptake, bioadhesion potential and in vitro drug release. The order of drug release from different inserts is HPMC E5 > PVP K90 > Sodium aliginate > Carrageenan > NaCMC > Xanthan Gum > Chitosan. | en_US |
dc.description.uri | Formulation and evaluation of ergotamine tartrate Lyophilized nasal insert | |
dc.identifier.doi | https://doi.org/ | |
dc.identifier.issn | 9751491 | |
dc.identifier.other | https://doi.org/ | |
dc.identifier.uri | https://t.ly/52XrE | |
dc.language.iso | English | en_US |
dc.relation.ispartofseries | International Journal of Pharmacy and Pharmaceutical Sciences | |
dc.relation.ispartofseries | 6 | |
dc.subject | October University for Modern Sciences and Arts | |
dc.subject | جامعة أكتوبر للعلوم الحديثة والآداب | |
dc.subject | University of Modern Sciences and Arts | |
dc.subject | MSA University | |
dc.subject | Carrageenan | en_US |
dc.subject | Chitosan | en_US |
dc.subject | Ergotamine Tartrate | en_US |
dc.subject | Insert | en_US |
dc.subject | Sodium aliginate | en_US |
dc.subject | Xanthan gum | en_US |
dc.subject | alginic acid | en_US |
dc.subject | carboxymethylcellulose | en_US |
dc.subject | carrageenan | en_US |
dc.subject | chitosan | en_US |
dc.subject | ergotamine tartrate | en_US |
dc.subject | hydroxypropylmethylcellulose | en_US |
dc.subject | polymer | en_US |
dc.subject | povidone | en_US |
dc.subject | xanthan | en_US |
dc.subject | article | en_US |
dc.subject | bioavailability | en_US |
dc.subject | controlled release formulation | en_US |
dc.subject | drug delivery system | en_US |
dc.subject | drug release | en_US |
dc.subject | drug screening | en_US |
dc.subject | excipient compatibility | en_US |
dc.subject | first pass effect | en_US |
dc.subject | freeze drying | en_US |
dc.subject | infrared spectroscopy | en_US |
dc.subject | nose cavity | en_US |
dc.subject | scanning electron microscopy | en_US |
dc.subject | viscosity | en_US |
dc.subject | water transport | en_US |
dc.title | Formulation and evaluation of ergotamine tartrate Lyophilized nasal insert | en_US |
dc.type | Article | en_US |
dcterms.isReferencedBy | Bertram, U., Bodmeier, R., Parameters affecting the drug release from in situ gelling nasal insert (2006) European Journal of Pharmaceutics and Biopharmaceutics, 63 (3), pp. 310-319; Sanders, S.W., Haering, N., Mosberg, H., Jaeger, H., Pharmacokinetics of ergotamine in healthy volunteers following oral and rectal dosing (1986) European Journal of Clinical Pharmacology, 30 (3), pp. 331-334; Hansen, F.P.T., Saxena, P.R., Dahl�f, C., Pascual, J., L�inez, M., Henry, P., Diener, H., Goadsby, P.J., Ergotamine in the acute treatment of migraine (2000) Brain: A Journal of Neurology, 123 (1), pp. 9-18; Gennaro, A.R., (2005) Remington: The science and practice of pharmacy, 1, p. 2393. , Lippincott Williams and Wilkins; Bertram, U., Bodmeier, R., In situ gelling, bioadhesive nasal inserts for extended drug delivery: In vitro characterization of a new nasal dosage form (2006) European Journal of Pharmaceutical Sciences, 27 (1), pp. 62-71; Fernandez, M., Plessing, C.V., Cardenas, G., Preparation and characterization of chitosan gels (2006) Journal of the Chilean Chemical Society, 51 (4), pp. 1022-1024; Farrow, F.D., Lowe, G.M., Neale, S.M., The flow of starch pastes. Flow at high and low rates of shear (1928) Journal of the Textile Institute Transactions, 19 (1), pp. T18-T31; Aburahma, M.H., Mahmoud, A.A., Biodegradable Ocular Inserts for Sustained Delivery of Brimonidine Tartarate: Preparation and In Vitro/In Vivo Evaluation (2011) AAPS PharmSciTech, 12 (4), pp. 1335-1347; Alfadhel, M., Puapermpoonsiri, U., Ford, S.J., McInnes, F.J., Walle, C.F.V.D., Lyophilized inserts for nasal administration harboring bacteriophage selective for Staphylococcus aureus: In vitro evaluation (2011) International Journal of Pharmaceutics, 416 (1), pp. 280-287; Nakamura, F., Ohtaa, M.R., Nagaic, Y., Tsuneji, In vitro and in vivo nasal mucoadhesion of some water-soluble polymers (1996) International Journal of Pharmaceutics, 134 (1-2), pp. 173-181; Luppi, B., Bigucci, F., Mercolini, L., Musenga, A., Sorrenti, M., Catenacci, L., Zecchi, V., Novel mucoadhesive nasal inserts based on chitosan/hyaluronate polyelectrolyte complexes for peptide and protein delivery (2009) Journal of Pharmacy and Pharmacology, 61 (2), pp. 151-157; El-ridy, M.S., Peck, G.E., Kildsig, D.O., Studies of Ergotamine Tartrate-Caffeine Interactions by Differential Scanning Calorimetry (1983) Drug Development and Industrial Pharmacy, 9 (3), pp. 459-471; Popa, E.G., Gomes, M.E., Reis, R.L., Cell Delivery Systems Using Alginate-Carrageenan Hydrogel Beads and Fibers for Regenerative Medicine Applications (2011) Biomacromolecules, 12 (11), pp. 3952-3961; Mesnukul, A., Yodkhum, K., Mahadlek, J., Phaechamud, T., Characterization of Indomethacin Release from Polyethylene Glycol Tablet Fabricated With Mold Technique (2010) Indian Journal of Pharmaceutical Sciences, 72 (1), pp. 92-100; Eouani, C., Piccerelle, P., Prinderre, P., Bourret, E., Joachim, J., In-vitro comparative study of buccal mucoadhesive performance of different polymeric films (2001) European Journal of Pharmaceutics and Biopharmaceutics, 52 (1), pp. 45-55; Khan, M.A., Studies of Swelling Effect and Drug Release in Hydrophilic Matrices Containing Different Grades of Polymers (2013) Research Journal of Pharmaceutical, Biological and Chemical Sciences, 4 (1), pp. 1241-1247; Shaikh, R., Singh, T.R.R., Garland, M.J., Woolfson, A.D., Donnelly, R.F., Mucoadhesive drug delivery systems (2011) Journal of Pharmacy and Bioallied Sciences, 3 (1), pp. 89-100; Tas, C., Ozkan, C.K., Savaser, A., Ozkan, Y., Tasdemir, U., Altunay, H., Nasal absorption of metoclopramide from different Carbopol 981 based formulations: In vitro, ex vivo and in vivo evaluation (2006) European Journal of Pharmaceutics and Biopharmaceutics, 64 (2), pp. 246-254; Berger, K.W., Neelissen, J.A., Bergenst�hl, B., The effect of rheological behaviour of a topical anaesthetic formulation on the release and permeation rates of the active compound (2001) European Journal of Pharmaceutical Sciences, 13 (3), pp. 309-318 | |
dcterms.source | Scopus |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- avatar_scholar_256.png
- Size:
- 6.31 KB
- Format:
- Portable Network Graphics
- Description: